Advertisement

Topics

Companies Related to "vaccines continue dominate cancer vaccines landscape" [Most Relevant Company Matches] RSS

23:46 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "vaccines continue dominate cancer vaccines landscape" found in our extensive corporate database of over 50,000 company records.

Showing "vaccines continue dominate cancer vaccines landscape" Companies 1–25 of 3,200+

Extremely Relevant

AKASAKA INTERNATIONAL CLINIC

It is a new and innovative cancer vaccine consisting of formalin-fixed or paraffin-embedded tissue fragments derived from patient's own cancer (tumor) and immunoadjuvants. It is one of the self-vaccines (auto-vaccines) without any problematic adverse side effects.


Novartis Vaccines and Diagnostics

Novartis Vaccines is a global leader in providing vaccines to protect against deadly meningococcal disease. Through industry-leading scientific expertise, the company is focused on extending critical meningococcal vaccines research. In addition to developing Menveo vaccine, Novartis Vaccines is developing a recombinant vaccine for its potential to provide broad coverage against multiple strains of...

MabVax Therapeutics Inc.

MabVax was formed to commercialize the work of Dr. Phil Livingston and colleagues at Memorial Sloan-Kettering Cancer Center (MSKCC) who over the last 25 years have developed monovalent cancer vaccines against ten distinct antigenic targets on various types of cancer cells. These vaccines target gangliosides and other carbohydrate antigens that are the most extensively expressed antigenic targe...


Cancer Vaccines Ltd

Cancer Vaccines Ltd is a biopharmaceutical company focused on the development and commercialisation of safe and effective therapeutic vaccines for the treatment of cancer. The company was founded in 1999 and won a DTI SMART Award.The attraction of a vaccination based approach to treating cancer is widely acknowledged, and many researchers and clinicians have worked in this area. Historically the a...

DCPrime

DCPrime develops off-the-shelf dendritic cell-based vaccines for a broad range of cancer types, based on its unique, proprietary technology platform, DCOne™. DCOne-based dendritic cell vaccines, in some indications loaded with cancer antigens for targeted treatment, are used as standardized, therapeutic products. The platform combines the power of den...

Inovio Biomedical Corporation

Inovio Biomedical is focused on the design, development, and delivery of a new generation of vaccines, called DNA vaccines, to prevent and treat cancers and infectious diseases. The company’s SynCon™ technology enables the design of “universal” vaccines capable of protecting against multiple – including newly emergent, unknown – stra...

Transgene Inc

Mission StatementTransgene is a biopharmaceutical company dedicated to the discovery and development of gene-based therapeutic vaccines and immunotherapy products for the treatment of cancer and infectious diseases.Business StrategyTransgene's business strategy is to develop therapeutic vaccines against cancer and infectious diseases based on its broad technology platform for gene delivery. Transg...

Longhorn Vaccines & Diagnostics

Longhorn Vaccines & Diagnostics is a private a biotech company located in San Antonio, TX that develops, and commercializes platform neutral RRT-PCR assays and develops vaccines for infectious diseases.

Madison Vaccines Incorporated

Wisconsin-based MVI is developing two plasmid DNA vaccines to treat men with prostate cancer. MVI has licensed patented technologies that were developed in the laboratory of Dr. Douglas McNeel at the University of Wisconsin-Madison. More information is available at www.madisonvaccines.com.

BioVaxys LLC

BioVaxys LLC, a privately-held, clinical stage biotechnology company that is developing highly-targeted, patient-specific, immunotherapeutic vaccines to treat various solid tumor types. The Company’s lead clinical program is a bihaptenized autologous vaccine that will initially be developed and marketed for melanoma and ovarian cancer. Earlier stage i...

Relevant

Advaxis, Incorporated

Based in North Brunswick, New Jersey, Advaxis is developing proprietary Listeria monocytogenes (Lm) cancer vaccines based on technology developed by Dr. Yvonne Paterson, professor of microbiology at the University of Pennsylvania and chairperson of Advaxis’ scientific advisory board. Advaxis is developing attenuated live Lm vaccines that deliver engin...

Inovio Pharmaceuticals, Inc.

Inovio is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases. The company’s SynCon™ vaccines are designed to provide broad cross-strain protection against known as well as newly emergent strains of pathogens such as influenza. When delivered with Inovio’s proprietary electroporation ...

Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc. is developing next generation therapeutic vaccines for the treatment of cancer and infectious diseases. The company's pharmacologically regulated DeCIDe(TM) vaccines are designed to kill targeted cells by inducing a potent, durable, fully activated antigen-specific TH1 immune response. Lead product BPX-101, an autologous DeCIDe(TM) vaccine, is in clinical development...

Immunovaccine Inc.

Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company’s DepoVax™ platform, a patented formulation that provides controlled and prolonged exposure of antigens and adjuvant to the immune system. Immunovaccine has advanced two T cell activation therapies for cancer through Phase 1 human clinical trials ...

Biomira

Biomira Inc. (TSE: BRA; Nasdaq: BIOM) is a product focused biotechnology company applying its proprietary immunotherapy and organic chemistry technologies for the development of cancer therapeutics. The Company's lead product, THERATOPE® vaccine, is currently being tested in a Phase III clinical trial for metastatic breast cancer. The Company's commitment to the development of products for the ...

Inviragen, Inc. and Duke-NUS

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's lead product candidate is a vaccine to protect against dengue fever. Inviragen is also developing vaccines to protect against hand, foot and mouth disease, chikungunya and Japanese encephalitis which affect millions of individuals in Asia. Vaccines in ...

Inviragen, Inc. and PharmaJet, Inc.

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's lead product candidate is a vaccine to protect against dengue fever. Inviragen is also developing vaccines to protect against hand, foot and mouth disease and Japanese encephalitis, both of which affect millions of children in Asia. Vaccines in preclin...

Indian Immunologicals Limited

Indian Immunologicals Ltd (IIL) is a wholly owned subsidiary of National Dairy Development Board, established in 1983. IIL's plant at Hyderabad is built in collaboration with Wellcome Foundation of U.K. In addition to Foot and Mouth Disease (FMD) vaccine under the flagship brand name "Raksha", IIL also produces a range of other veterinary vaccines such as anti-rabies vaccine, Thileriosis vaccine, ...

Vaxon Biotech.

Vaxon Biotech, founded in early 2004 and based in Evry Genopole - France, is a product-driven biopharmaceutical company focusing on the discovery and development of innovative vaccines for the treatment of malignancies, including prostate, lung, breast and colon cancer. The company is based on an original discovery made by Dr. Kostas Kosmatopoulos and his team: optimized cryptic peptides. Vaxon Bi...

Chiron

Chiron Corporation, headquartered in Emeryville, California, is a global pharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a difference in people's lives. The company has a strategic focus on cancer and infectious disease. Chiron applies its advanced understanding of the biology of cancer and infectious disease to develop prod...

Chiron Vision

Chiron Corporation, headquartered in Emeryville, California, is a global pharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a difference in people's lives. The company has a strategic focus on cancer and infectious disease. Chiron applies its advanced understanding of the biology of cancer and infectious disease to develop prod...

Sinovac Biotech Ltd.

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccine products include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), and Anflu(R) (influenza). PanfluTM, Sinovac's pandemic influenza vaccine (H5N1), has already b...

Oxxon Pharmaccines Limited

Oxxon Pharmaccines™ Ltd is a biotechnology company developing novel pharmaccines (therapeutic vaccines) based on its unique PrimeBoost technologies for the treatment of chronic infectious diseases and cancer. We currently have products in clinical trials for the treatment of melanoma and hepatitis B virus, and our founding collaborators have ongoing clinical programmes developing preventative va...

GenPhar, Inc

GenPhar, Inc. is a biopharmaceutical company dedicated to becoming a leader in developing and producing prophylactic and therapeutic vaccines to protect against the world's most dangerous diseases. GenPhar’s scientists have developed a complex and adaptive, proprietary vaccine technology designed to develop multivalent vaccines (protects against multiple virus strains) .Successful, safe vaccinat...

Avant Immunotherapeutics

AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. The company is developing a broad portfolio of vaccines against viral and bacterial diseases, including single-dose oral vaccines aimed a protecting travelers from cholera, typhoid fever and other illnesses. In addition, the co...


More From BioPortfolio on "vaccines continue dominate cancer vaccines landscape"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks